A DOUBLE-BLIND TRIAL WITH BACLOFEN (LIORESAL®) AND DIAZEPAM IN SPASTICITY DUE TO MULTIPLE SCLEROSIS

PRELIMINARY TRIAL OF CARISOPRODOL IN MULTIPLE SCLEROSIS.

1964 • 1,491 citations

Glutamate and γ-Aminobutyric Acid in Brain

1970 • 269 citations

ISOLATION OF FACTOR I

1957 • 212 citations

Baclofen in the Treatment of Spasticity

1971 • 121 citations

‘Second look’ operation for ovarian dysgerminoma

1972 • 118 citations

Spasticity: A Topical Survey

1973 • 108 citations

Diazepam and presynaptic inhibition

1971 • 74 citations

GABA DERIVATIVE IN SPASTICITY (β-(4-Chlorophenyl)-γ-Aminobutyric Acid, Ciba 34.647-Bα)

1970 • 67 citations

The action of a GABA derivative in human spasticity

1971 • 64 citations

DIFFERENCES IN EFFECTS IN GAMMA AND ALPHA SPASTICITY INDUCED BY THE GABA DERIVATIVE BACLOFEN (LIORESAL)

1973 • 53 citations

Sites of Action of a New Muscle Relaxant (Baclofen, Lioresal®, Ciba 34 647–Ba)

1974 • 47 citations

[Double-blind study on the antispastic effect of beta-94-chlorphenyl)-gamma aminobutyric acid (CIBA) in multiple sclerosis].

1968 • 28 citations

Pharmacological aspects of spasticity with special reference to Lioresal.

1972 • 20 citations